MEZNUVA

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Jul 2024 filing date already counts against anyone who files later.

Record

Serial number

98670993

Mark type

Word mark

Filed

29 Jul 2024

Published for opposition

08 Jul 2025

Attorney of record

Xiomara Triana

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes.

Owner

• Celgene Corporation, Princeton, NJ, US
• Celgene Corporation, Princeton, NJ, US

Prosecution history

• 26 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 26 Aug 2026 — SOU EXTENSION 2 GRANTED
• 26 Aug 2026 — SOU EXTENSION 2 FILED
• 26 Aug 2026 — SOU TEAS EXTENSION RECEIVED
• 12 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 12 Feb 2026 — SOU EXTENSION 1 GRANTED
• 12 Feb 2026 — SOU EXTENSION 1 FILED
• 12 Feb 2026 — SOU TEAS EXTENSION RECEIVED
• 02 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 08 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 08 Jul 2025 — PUBLISHED FOR OPPOSITION
• 02 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 03 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 14 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 14 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE